Newsletters
- All
- Can you help?
- CARB-X
- CDC
- FDA
- Government Action
- Jobs
- Meetings
- PK & PK-PD
- Push/Pull
- R&D Insight
- RFPs
- Something Different
- Summaries
- Wellcome Trust
- WHO
- Wonkish
- All
- Can you help?
- CARB-X
- CDC
- FDA
- Government Action
- Jobs
- Meetings
- PK & PK-PD
- Push/Pull
- R&D Insight
- RFPs
- Something Different
- Summaries
- Wellcome Trust
- WHO
- Wonkish
A Nature Article, a PASTEUR Act Op-Ed, and a VERY Important Phone Number
Dear All, First, Nature published an excellent article entitled “The importance of antimicrobial resistance in medical mycology” by Gow et al. …
Raising awareness of AMR: WHO report on best approaches
Dear All, In addition to forming the inaugural WHO Task Force of AMR Survivors, the WHO has also recently released …
Support the FORWARD and PASTEUR Acts by signing a letter!
Dear All, I’ve written before about the FORWARD Act, a bill introduced last year into Congress with the goal of …
Hot meetings x 3! FDA Microbiome AdComm, Diagnostic devices, ASM-ESCMID developer meeting
Dear All, I think it’s worth a newsletter to call your attention to several upcoming meetings. In addition to the …
WHO Forming Task Force of Antimicrobial Resistance Survivors
Dear All, The WHO has announced a call for expressions of interests from AMR survivors and their caregivers to serve in …
16 Positions Available at PACCARB! Apply Now!
Dear All, The US Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB) has announced it is looking for new members! As …
CDC-FDA webinar: Developing drugs to prevent healthcare-associated infections (30 Aug 2022)
Dear All, A quick note today to call your attention to an upcoming webinar that will be of wide interest. …
US Senate and House / Call for Pull incentives in FY23 budget
Dear All, The US Government is now building its budget for FY23 (Federal Year 2023, really runs 1 Oct 22 …
WHO Vaccine pipeline review; CDC on impact of COVID on AMR
Dear All, WHO continues to crank out those pipeline reviews … now we have one for bacterial vaccines! Go here …
IDWeek 2022: New pipeline sessions seek presentation of therapeutics and diagnostics!
Dear All: I have learned that the program for IDWeek 2022 will have specific dedicated pipeline sessions for therapeutics and …
Leaky pipe(line)s, Part 2 / CARB-X reboot / WHO 2021 pipeline review
Dear All, We have a 3-part discussion today on the theme of “I want a new drug … so how …
Antibiotic procurement models for LMICs / G7 Leaders call for Pull!
Dear All, Two stops on our tour today: (i) an excellent survey of incentive models and (ii) a final communique …
Leaky pipe(lines) / When is a molecule a drug? (Part 1 of 2)
Dear All, I was fascinated by this recent paper in AAC: Neha K. Prasad, Ian B. Seiple, Ryan T. Cirz, …
FDA/CVM: Antimicrobial use in companion animals
Dear All, Post-newsletter addendum: I’ve learned that USDA will host a 10 Aug 2022 (virtual, 10a-4.30p ET) workshop on AMR in …
ATMF on Access in LMICs/Progress, but wishing for more
Dear All, Last fall, the team at ATMF (Access to Medicine Foundation) released the 3rd update to the AMR Benchmark …
Climate change and AMR: NIH grant opportunity!
Dear All, A Notice of Special Interest (a “NOSI” in NIH jargon; here’s the link: NOT-ES-22-006) from the NIH could be …
Notable reports: Incentives (WHO, AMR Hub); Strategy (BARDA); Capacity Building (UK Fleming Fund, US CDC)
Dear All, Four big reports have recently been released and are very much worth reviewing. First, the Global AMR R&D …
Antibacterial guidance (including pediatrics): Parallel EMA+FDA updates
Dear All (Wonkish alert! Get some coffee and settle in!), Almost in parallel, EMA and FDA have released updates to …
G7 Health Ministers: Pull incentives to support stewardship, access, and innovation
Dear All, The G7 Health Ministers met 19-20 May 2022 in Berlin. As you might expect, their communique covered a …
CARB-X renewed x 10 years! Strong calls for PASTEUR!
Dear All, On the heels of yesterday’s (i) patient-focused meeting at the Capitol yesterday where 5 Members of Congress spoke …
